Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Clemens Wittenbecher, Ph.D.

Concepts

This page shows the publications Clemens Wittenbecher has written about Cohort Studies.
Connection Strength

0.135
  1. Plasma N-Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study. Diabetes Care. 2020 03; 43(3):661-668.
    View in: PubMed
    Score: 0.043
  2. Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants. PLoS One. 2015; 10(9):e0138480.
    View in: PubMed
    Score: 0.032
  3. Associations of network-derived metabolite clusters with prevalent type 2 diabetes among adults of Puerto Rican descent. BMJ Open Diabetes Res Care. 2021 08; 9(1).
    View in: PubMed
    Score: 0.012
  4. Dairy consumption, plasma metabolites, and risk of type 2 diabetes. Am J Clin Nutr. 2021 07 01; 114(1):163-174.
    View in: PubMed
    Score: 0.012
  5. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study. Eur J Nutr. 2019 Jun; 58(4):1673-1686.
    View in: PubMed
    Score: 0.010
  6. Red meat consumption and risk of cardiovascular diseases-is increased iron load a possible link? Am J Clin Nutr. 2018 01 01; 107(1):113-119.
    View in: PubMed
    Score: 0.009
  7. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci Rep. 2017 10 26; 7(1):14171.
    View in: PubMed
    Score: 0.009
  8. Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study. Atherosclerosis. 2016 08; 251:415-421.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.